Source comparison
Quickcomparison
Dose Range Hexarelin 100–200 mcg Ipamorelin 100–300 mcg Frequency Once daily Multiple times daily Administration Subcutaneous injection Cycle Length 8-12 weeks Onset Speed Rapid (hours to days) Moderate (1-2 weeks) Evidence Level Moderate human trials (Phase 1
This comparison does not assign a generated winner or score.
- Dose Range
- Hexarelin
- 100–200 mcg
- Ipamorelin
- 100–300 mcg
- Frequency
- Once daily
- Multiple times daily
- Administration
- Subcutaneous injection
- Cycle Length
- 8-12 weeks
- Onset Speed
- Rapid (hours to days)
- Moderate (1-2 weeks)
- Evidence Level
- Moderate human trials (Phase 1-2)
- Efficacy